$2.44B
Revenue
$-51.00M
Net Income
51.73%
Gross Margin
0.99%
Op. Margin
$529.50M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Jun 30, 2025) |
FY 2024 (Jun 30, 2024) |
FY 2023 (Jun 30, 2023) |
FY 2022 (Jun 30, 2022) |
FY 2021 (Jun 30, 2021) |
FY 2020 (Jun 30, 2020) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $2.44B | $2.49B | $2.70B | $2.80B | $3.58B | $4.02B | $1.83B |
| Revenue Growth % | -2.1% | -7.8% | -3.6% | -21.8% | -10.9% | 120.3% | nan% |
| Cost of Revenue | $1.18B | $1.22B | $1.49B | $1.88B | $2.88B | $2.57B | $989.10M |
| Gross Profit | $1.26B | $1.27B | $1.21B | $923.50M | $698.40M | $1.45B | $836.70M |
| Gross Margin % | 51.7% | 50.9% | 44.7% | 33.0% | 19.5% | 36.1% | 45.8% |
| Operating Expenses | $1.24B | $1.30B | $1.74B | $2.12B | $3.43B | $1.64B | $917.60M |
| Research & Development | $242.50M | $234.20M | $304.80M | $318.40M | $359.50M | $247.80M | $89.00M |
| Operating Income | $24.20M | $-36.20M | $-529.00M | $-1.20B | $-2.73B | $-187.80M | $-80.80M |
| Operating Margin % | 1.0% | -1.5% | -19.6% | -42.8% | -76.3% | -4.7% | -4.4% |
| Interest Expense | $227.60M | $127.20M | $95.60M | $97.10M | $43.00M | $14.80M | $2.00M |
| Interest Income | $35.90M | $32.70M | $35.10M | $26.40M | $2.30M | $7.90M | $18.20M |
| Other Income/Expense | $-200.00K | $100.00K | $700.00K | $2.90M | $-1.50M | $100.00K | $-3.80M |
| Income Before Tax | $-48.70M | $-115.60M | $-552.10M | $-1.26B | $-2.81B | $-198.20M | $-68.40M |
| Income Tax Expense | $2.40M | $3.40M | $-200.00K | $3.70M | $19.60M | $-9.20M | $3.30M |
| Net Income | $-51.00M | $-118.90M | $-551.90M | $-1.26B | $-2.83B | $-189.00M | $-71.60M |
| Net Margin % | -2.1% | -4.8% | -20.4% | -45.1% | -78.9% | -4.7% | -3.9% |
| Basic EPS | -0.12 | -0.30 | -1.51 | -3.64 | -8.77 | -0.64 | -0.32 |
| Diluted EPS | -0.12 | -0.30 | -1.51 | -3.64 | -8.77 | -0.64 | -0.32 |
| Basic Shares Outstanding | 421.3M | 390.0M | 365.5M | 346.7M | 322.4M | 293.9M | 221.0M |
| Diluted Shares Outstanding | 421.3M | 390.0M | 365.5M | 346.7M | 322.4M | 293.9M | 221.0M |
| Breakdown | FY 2025 (Jun 30, 2025) |
FY 2024 (Jun 30, 2024) |
FY 2023 (Jun 30, 2023) |
FY 2022 (Jun 30, 2022) |
FY 2021 (Jun 30, 2021) |
FY 2020 (Jun 30, 2020) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.04B | $697.60M | $813.90M | $1.25B | $1.13B | $1.04B |
| Accounts Receivable | $101.20M | $103.60M | $97.20M | $83.60M | $71.40M | $34.60M |
| Inventory | $205.60M | $329.70M | $522.60M | $1.10B | $937.10M | $244.50M |
| Other Current Assets | $91.30M | $135.10M | $205.40M | $192.50M | $202.80M | $124.50M |
| Total Current Assets | $1.44B | $1.27B | $1.64B | $2.63B | $2.82B | $2.16B |
| Property Plant & Equipment | $239.00M | $353.70M | $444.80M | $610.90M | $591.90M | $242.30M |
| Goodwill | $41.20M | $41.20M | $41.20M | $41.20M | $210.10M | $39.10M |
| Intangible Assets | $5.60M | $15.00M | $25.60M | $41.30M | $247.90M | $16.00M |
| Other Non-current Assets | $16.80M | $21.00M | $22.70M | $34.30M | $36.70M | $31.80M |
| Total Assets | $2.13B | $2.19B | $2.77B | $4.03B | $4.49B | $2.98B |
| Accounts Payable | - | - | - | - | - | $135.80M |
| Accrued Liabilities | - | - | - | - | - | $225.90M |
| Deferred Revenue | $150.70M | $163.70M | $187.30M | $201.10M | $164.80M | $363.60M |
| Other Current Liabilities | $2.00M | $3.90M | $4.60M | $13.20M | $27.20M | $10.00M |
| Total Current Liabilities | $803.90M | $685.20M | $761.40M | $1.11B | $1.24B | $772.20M |
| Other Non-current Liabilities | $37.20M | $25.70M | $30.10M | $50.70M | $38.30M | $23.40M |
| Total Liabilities | $2.54B | $2.70B | $3.06B | $3.44B | $2.73B | $1.30B |
| Common Stock | - | - | - | - | - | - |
| Retained Earnings | $-5.60B | $-5.48B | $-4.93B | $-3.71B | $-883.00M | $-693.90M |
| Total Stockholders Equity | $-413.80M | $-519.10M | $-295.10M | $592.90M | $1.75B | $1.68B |
| Total Liabilities & Equity | $2.13B | $2.19B | $2.77B | $4.03B | $4.49B | $2.98B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Jun 30, 2025) |
FY 2024 (Jun 30, 2024) |
FY 2023 (Jun 30, 2023) |
FY 2022 (Jun 30, 2022) |
FY 2021 (Jun 30, 2021) |
FY 2020 (Jun 30, 2020) |
|---|---|---|---|---|---|---|---|
| Net Income | $-143.80M | $-118.90M | $-551.90M | $-1.26B | $-2.83B | $-189.00M | $-71.60M |
| Depreciation & Amortization | $138.60M | $89.70M | $108.80M | $124.30M | $142.80M | $63.80M | $40.20M |
| Stock-based Compensation | $379.70M | $229.60M | $311.70M | $405.00M | $328.40M | $194.00M | $88.80M |
| Change in Receivables | $-40.00M | $-2.80M | $7.00M | $13.80M | $12.80M | $-15.10M | $-11.30M |
| Change in Inventory | $-102.20M | $-136.50M | $-163.00M | $-537.50M | $398.60M | $587.20M | $96.80M |
| Operating Cash Flow | $548.70M | $333.00M | $-66.10M | $-387.60M | $-2.02B | $-239.70M | $376.40M |
| Capital Expenditure | $19.20M | $9.30M | $19.70M | $82.40M | $337.30M | $241.00M | $156.40M |
| Acquisitions | - | - | - | - | $11.00M | $478.20M | $45.00M |
| Sales of Investments | - | - | - | - | $211.00M | $665.90M | $435.40M |
| Investing Cash Flow | $-19.40M | $-5.10M | $26.80M | $-69.90M | $153.30M | $-585.10M | $-741.30M |
| Debt Repayment | $17.50M | $10.00M | $742.50M | $7.50M | - | - | - |
| Stock Repurchased | - | - | - | - | - | - | - |
| Financing Cash Flow | $-2.60M | $1.70M | $-94.40M | $76.80M | $2.02B | $916.80M | $1.24B |
| Net Change in Cash | $536.20M | $334.90M | $-134.60M | $-372.20M | $121.90M | $98.70M | $874.00M |
SEC Filing Format - Data shown as it appears in the Q2 2026 (10-Q) filing
Period ended: Dec 31, 2025
Condensed Consolidated Statements of Operations
| Description | Dec 31, 2025 | Dec 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $656.50M | - | $1.21B | - |
| Cost of Revenue | $325.20M | - | $592.30M | - |
| Gross Profit | $331.30M | - | $615.10M | - |
| Operating Expenses | $345.60M | - | $588.00M | - |
| Research & Development | $65.00M | - | $127.10M | - |
| Operating Income | $-14.30M | - | $27.00M | - |
| Interest Expense | $31.50M | - | $67.10M | - |
| Interest Income | $9.20M | - | $18.90M | - |
| Other Income/Expense | $100.00K | - | $-300.00K | - |
| Income Before Tax | $-39.00M | - | $-24.40M | - |
| Income Tax Expense | $-200.00K | - | $500.00K | - |
| Net Income | $-38.80M | - | $-24.80M | - |
| Basic EPS | -0.09 | - | -0.06 | - |
| Diluted EPS | -0.09 | - | -0.06 | - |
Condensed Consolidated Balance Sheets
| Description | Dec 31, 2025 | Jun 30, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $1.18B | $1.04B |
| Accounts Receivable | $94.60M | $101.20M |
| Inventory | $214.90M | $205.60M |
| Other Current Assets | $67.00M | $91.30M |
| Total Current Assets | $1.56B | $1.44B |
| Property Plant & Equipment | $191.60M | $239.00M |
| Goodwill | $44.00M | $41.20M |
| Intangible Assets | $1.10M | $5.60M |
| Other Non-current Assets | $17.50M | $16.80M |
| Total Assets | $2.16B | $2.13B |
| Deferred Revenue | $155.70M | $150.70M |
| Other Current Liabilities | $3.30M | $2.00M |
| Total Current Liabilities | $784.80M | $803.90M |
| Long-term Debt | $1.53B | - |
| Other Non-current Liabilities | $36.00M | $37.20M |
| Total Liabilities | $2.49B | $2.54B |
| Retained Earnings | $-5.63B | $-5.60B |
| Total Stockholders Equity | $-326.70M | $-413.80M |
| Total Liabilities & Equity | $2.16B | $2.13B |
Condensed Consolidated Statements of Cash Flows
| Description | Dec 31, 2025 | Dec 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-38.80M | - | $-24.80M | - |
| Depreciation & Amortization | - | - | $32.10M | - |
| Stock-based Compensation | - | - | $102.90M | - |
| Change in Receivables | - | - | $-6.50M | - |
| Change in Inventory | - | - | $4.30M | - |
| Operating Cash Flow | - | - | $143.80M | - |
| Capital Expenditure | - | - | $5.40M | - |
| Acquisitions | - | - | $2.20M | - |
| Investing Cash Flow | - | - | $-7.60M | - |
| Debt Repayment | - | - | $5.00M | - |
| Financing Cash Flow | - | - | $-2.60M | - |
| Net Change in Cash | - | - | $137.40M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.